Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris et al. · Journal of Clinical Oncology · 2006 · 1.6K citations

Medicine, Oncology, Surgery +8

Mitotic Degradation of Human Thymidine Kinase 1 Is Dependent on the Anaphase-Promoting Complex/Cyclosome–Cdh1-Mediated Pathway

Po‐Yuan Ke, Zee-Fen Chang · Molecular and Cellular Biology · 2003 · 147 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis.

Michael Kauffman, Thomas J. Kelly · Molecular and Cellular Biology · 1991 · 144 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma

J. Simon Gronowitz, Hans Hagberg, Clas F. R. Källander et al. · British Journal of Cancer · 1983 · 135 citations

Medicine, Oncology, Molecular Oncology +8

Clinical Significance and Prognostic Value of CA72‐4 Compared with CEA and CA19‐9 in Patients with Gastric Cancer

Marc Ychou, Jacqueline Duffour, A. Kramar et al. · Disease Markers · 2000 · 125 citations · Full text

Medicine, Oncology, Pathology +17